Who is the CEO of Immunotech Laboratories, Inc.?

The CEO of Immunotech Laboratories, Inc. is Harry H. Zhabilov Jr., BSc, McS Science.

What industry does Immunotech Laboratories, Inc. belong to?

Immunotech Laboratories, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector.

Where is Immunotech Laboratories, Inc. headquartered?

Immunotech Laboratories, Inc. is headquartered at 120 West Pomona Avenue, Monrovia, US.

What is the IPO date of Immunotech Laboratories, Inc.?

Immunotech Laboratories, Inc. went public on December 1, 2022.

How many employees does Immunotech Laboratories, Inc. have?

Immunotech Laboratories, Inc. has approximately 4 full-time employees.

Immunotech Laboratories, Inc.

IMMB•PNK

Healthcare

Medical - Pharmaceuticals

$0.00

$0.00(0.00%)

Immunotech Laboratories, Inc. (IMMB) Company Profile & Overview

Explore Immunotech Laboratories, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Immunotech Laboratories, Inc. (IMMB) Company Profile & Overview

Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Eco-Petroleum Solutions, Inc.

SectorHealthcare

IndustryMedical - Pharmaceuticals

CEOHarry H. Zhabilov Jr., BSc, McS Science

Contact Information

https://www.immunotechlab.com

120 West Pomona Avenue, Monrovia

Company Facts

4 Employees

IPO DateDec 1, 2022

CountryUS

Actively Trading

Frequently Asked Questions

;